EMBC — EMBECTA CORP (Healthcare >> Medical Instruments & Supplies)
EMBC FAQ
What is EMBC's P/E ratio?
EMBECTA CORP (EMBC) currently trades at a P/E ratio of 1.80.
What is EMBC's ROE?
EMBECTA CORP reports a Return on Equity (ROE) of -17.87%.
What is EMBC's dividend yield?
EMBECTA CORP offers a dividend yield of 17.60%.
What is EMBC's Deepscope Quality Score?
Deepscope rates EMBC's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy EMBC?
Deepscope's AI Timing Score for EMBC is 28 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does EMBC belong to?
EMBECTA CORP is classified under the Healthcare >> Medical Instruments & Supplies sector on the NASDAQ exchange.
|
USD 3.38
Price
-0.03
(-0.88%)
Day Change
|
|
|---|
EMBC, the overall quality is not good ( Quality = 38) and the timing to buy is ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not quite good , financial health is not good , and ability to make profit is ok , ...
| Quality Factors |
|
54% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 95 |
| Magic Formula Rank by ROA |
191
|
| Magic Formula Rank by ROE |
191
|
| Magic Formula Rank by ROIC |
71
GOOD
|
| Price | 3.38 |
| PBV / Sector |
-0.32 / 4.41
|
| Earning Per Share | 1.88 |
| PE / Sector |
1.80 / 36.90
GREAT
|
| PEG or PE/Growth / Sector |
-0.14 / -0.97
|
| Average 1M Daily Value |
8.97 M
|
| Average 1W Daily Value |
5.71 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
41% |
| Ability to Make Profit |
|
66% |
| Return to Investors |
|
100% |
| Registration Details |
| Analyze Date | 2026-06-06 09:09:23 |
| Symbol | EMBC |
| Name | EMBECTA CORP |
| Sector | Healthcare >> Medical Instruments & Supplies |
| Market | NASDAQ |
| Listed Shares | 59.33 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 201.17 / 16,249.68 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 300 Kimball Drive, Parsippany, NJ, United States, 07054
Phone: 862 401 0000
Website: https://www.embecta.com
Employees: 1,850
Description: Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
ME vs SECTOR Healthcare >> Medical Instruments & Supplies
Click a bubble to view stock details · Bubble size represents market capitalization share
Google